Rhythm Pharmaceuticals, Inc.
HealthcareNASDAQ:RYTM · NASDAQ Global Market
+$0.72 today
Vol 0.55M · Avg 0.80M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+40.51%
Period High
$117.62
Period Low
$61.45
Latest
$88.38
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Revolution Medicines, Inc.
NASDAQ:RVMD
$32.71B
Nuvalent, Inc.
NASDAQ:NUVL
$9.07B
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
$7.06B
Arcellx, Inc.
ACLX
$6.73B
Akero Therapeutics, Inc.
AKRO
$4.50B
Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
$3.90B
Relay Therapeutics, Inc.
NASDAQ:RLAY
$2.59B
Stoke Therapeutics, Inc.
NASDAQ:STOK
$1.86B
uniQure N.V.
NASDAQ:QURE
$1.74B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.62B
Viridian Therapeutics, Inc.
NASDAQ:VRDN
$1.47B
Ventyx Biosciences, Inc.
VTYX
$1.00B
MeiraGTx Holdings plc
NASDAQ:MGTX
$888.13M
Cullinan Therapeutics, Inc.
NASDAQ:CGEM
$841.97M
Solid Biosciences Inc.
NASDAQ:SLDB
$556.28M
Arvinas, Inc.
NASDAQ:ARVN
$489.07M
Rocket Pharmaceuticals, Inc.
NASDAQ:RCKT
$300.28M
Inozyme Pharma, Inc.
INZY
$258.25M
Atrium Therapeutics, Inc.
NASDAQ:RNA
$211.60M
Black Diamond Therapeutics, Inc.
NASDAQ:BDTX
$100.28M
Pliant Therapeutics, Inc.
NASDAQ:PLRX
$69.97M
What is the latest RYTM filing?
The latest filing shown is DEFA14A dated May 29, 2026.
How many recent filings does RYTM have?
Intrinsic Alpha currently shows 20 recent filings for RYTM.
Explore More
Continue the stock analysis
Jump to another research area for this company.